nach oben

Erschienen in:

01.01.2023 | Case report

Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab

Lack of efficacy, off-label use and COVID-19: 2 case reports

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

…

Santarelli IM, et al. Clinical Course of COVID-19 and Cycle Threshold in Patients with Haematological Neoplasms. Prague Medical Report 123: 250-257, No. 4, Jan 2022. Available from: URL: http://doi.org/10.14712/23362936.2022.23

Titel: Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab
Lack of efficacy, off-label use and COVID-19: 2 case reports
Publikationsdatum: 01.01.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30579-9